|
gptkbp:instanceOf
|
gptkb:biotechnology
|
|
gptkbp:acquiredBy
|
gptkb:Emergent_BioSolutions
|
|
gptkbp:acquisitionYear
|
2014
|
|
gptkbp:country
|
gptkb:Canada
|
|
gptkbp:founded
|
1984
|
|
gptkbp:headquarters_location
|
gptkb:Winnipeg,_Manitoba,_Canada
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Cangene Corporation
|
|
gptkbp:industry
|
gptkb:biotechnology
|
|
gptkbp:listedOn
|
gptkb:Toronto_Stock_Exchange
|
|
gptkbp:notableProduct
|
gptkb:Botulism_Antitoxin
gptkb:Hepatitis_B_Immune_Globulin
gptkb:Vaccinia_Immune_Globulin
gptkb:WinRho_SDF
|
|
gptkbp:numberOfEmployees
|
~500 (prior to acquisition)
|
|
gptkbp:parentOrganization
|
gptkb:Emergent_BioSolutions
|
|
gptkbp:specializesIn
|
plasma-derived therapeutics
biopharmaceuticals
|
|
gptkbp:stockSymbol
|
gptkb:CNJ
|
|
gptkbp:bfsParent
|
gptkb:Emergent_BioSolutions
|
|
gptkbp:bfsLayer
|
5
|